Indian pharma firms set to tap reviving IPO market
This article was originally published in Scrip
Executive Summary
A clutch of Indian pharmaceutical companies are expected to consider the initial public offering (IPO) route to raise funds over the next few months, as the market for such floats looks set for revival.